198 related articles for article (PubMed ID: 1360088)
1. Prognostic significance of cytoplasmic p53 oncoprotein in colorectal adenocarcinoma.
Sun XF; Carstensen JM; Zhang H; Stål O; Wingren S; Hatschek T; Nordenskjöld B
Lancet; 1992 Dec; 340(8832):1369-73. PubMed ID: 1360088
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of p53 nuclear and cytoplasmic overexpression in right and left colorectal adenocarcinomas.
Sun XF; Carstensen JM; Zhang H; Arbman G; Nordenskjöld B
Eur J Cancer; 1996 Oct; 32A(11):1963-7. PubMed ID: 8943682
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical expression of bcl-2 in Dukes' stage B and C colorectal carcinoma patients: correlation with p53 and ki-67 in evaluating prognostic significance.
Zavrides H; Zizi-Sermpetzoglou A; Elemenoglou I; Papatheofanis I; Peros G; Athanasas G; Panousopoulos D
Pol J Pathol; 2005; 56(4):179-85. PubMed ID: 16477877
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of p53 expression in relation to DNA ploidy in colorectal adenocarcinoma.
Sun XF; Carstensen JM; Stål O; Zhang H; Nilsson E; Sjödahl R; Nordenskjöld B
Virchows Arch A Pathol Anat Histopathol; 1993; 423(6):443-8. PubMed ID: 8291217
[TBL] [Abstract][Full Text] [Related]
5. Cytoplasmic accumulation of p53 protein: an independent prognostic indicator in colorectal adenocarcinomas.
Bosari S; Viale G; Bossi P; Maggioni M; Coggi G; Murray JJ; Lee AK
J Natl Cancer Inst; 1994 May; 86(9):681-7. PubMed ID: 8158699
[TBL] [Abstract][Full Text] [Related]
6. p53 and Ki-ras as prognostic factors for Dukes' stage B colorectal cancer.
Bouzourene H; Gervaz P; Cerottini JP; Benhattar J; Chaubert P; Saraga E; Pampallona S; Bosman FT; Givel JC
Eur J Cancer; 2000 May; 36(8):1008-15. PubMed ID: 10885605
[TBL] [Abstract][Full Text] [Related]
7. Clinico-pathological correlation and prognostic significance of nuclear p53 protein in colorectal cancer. Colorectal Cancer Study Group of the University and Health Care District of Modena.
Fante R; Di Gregorio C; Losi L; Roncucci L; Ponz de Leon M
Ital J Gastroenterol; 1996 May; 28(4):205-10. PubMed ID: 8842835
[TBL] [Abstract][Full Text] [Related]
8. Combined role of tumor angiogenesis, bcl-2, and p53 expression in the prognosis of patients with colorectal carcinoma.
Giatromanolaki A; Stathopoulos GP; Tsiompanou E; Papadimitriou C; Georgoulias V; Gatter KC; Harris AL; Koukourakis MI
Cancer; 1999 Oct; 86(8):1421-30. PubMed ID: 10526268
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of cytoplasmic p53 overexpression in colorectal cancer. An immunohistochemical analysis.
Flamini G; Curigliano G; Ratto C; Astone A; Ferretti G; Nucera P; Sofo L; Sgambato A; Boninsegna A; Crucitti F; Cittadini A
Eur J Cancer; 1996 May; 32A(5):802-6. PubMed ID: 9081357
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of p53 and c-erbB-2 immunohistochemical evaluation in colorectal adenocarcinoma.
Lazaris AC; Theodoropoulos GE; Anastassopoulos P; Nakopoulou L; Panoussopoulos D; Papadimitriou K
Histol Histopathol; 1995 Jul; 10(3):661-8. PubMed ID: 7579815
[TBL] [Abstract][Full Text] [Related]
11. Stereologic estimates of volume-weighted mean nuclear volume in colorectal adenocarcinoma: correlation with histologic grading, Dukes' staging, cell proliferation activity and p53 protein expression.
Martín R; Nieto S; Santamaría L
Gen Diagn Pathol; 1997 Jul; 143(1):29-38. PubMed ID: 9269906
[TBL] [Abstract][Full Text] [Related]
12. Loss of p27 expression predicts poor prognosis in patients with Dukes' B stage or proximal colorectal cancer.
Zhang H; Sun XF
Int J Oncol; 2001 Jul; 19(1):49-52. PubMed ID: 11408921
[TBL] [Abstract][Full Text] [Related]
13. Apoptosis and cell-cycle regulatory proteins in colorectal carcinoma: relationship to tumour stage and patient survival.
Elkablawy MA; Maxwell P; Williamson K; Anderson N; Hamilton PW
J Pathol; 2001 Aug; 194(4):436-43. PubMed ID: 11523051
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of four antibodies in detecting p53 protein for predicting clinicopathological and prognostic significance in colorectal adenocarcinoma.
Zhang Hong
Clin Cancer Res; 1999 Dec; 5(12):4126-32. PubMed ID: 10632350
[TBL] [Abstract][Full Text] [Related]
15. p53 nuclear accumulation and multiploidy are adverse prognostic factors in surgically resected stage II colorectal cancers independent of fluorouracil-based adjuvant therapy.
Buglioni S; D'Agnano I; Vasselli S; Perrone Donnorso R; D'Angelo C; Brenna A; Benevolo M; Cosimelli M; Zupi G; Mottolese M
Am J Clin Pathol; 2001 Sep; 116(3):360-8. PubMed ID: 11554164
[TBL] [Abstract][Full Text] [Related]
16. p53 mutation found to be a significant prognostic indicator in distal colorectal cancer.
Okubo R; Masuda H; Nemoto N
Oncol Rep; 2001; 8(3):509-14. PubMed ID: 11295071
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of multiple bio-pathological factors in colorectal adenocarcinomas: independent prognostic role of p53 and bcl-2.
Buglioni S; D'Agnano I; Cosimelli M; Vasselli S; D'Angelo C; Tedesco M; Zupi G; Mottolese M
Int J Cancer; 1999 Dec; 84(6):545-52. PubMed ID: 10567896
[TBL] [Abstract][Full Text] [Related]
18. Bax protein expression in colorectal cancer: association with p53, bcl-2 and patterns of relapse.
Giatromanolaki A; Sivridis E; Stathopoulos GP; Fountzilas G; Kalofonos HP; Tsamandas A; Vrettou E; Scopa C; Polychronidis A; Simopoulos K; Koukourakis MI
Anticancer Res; 2001; 21(1A):253-9. PubMed ID: 11299743
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical expression of bcl-2 in UICC stage I and III colorectal carcinoma patients: correlation with c-erbB-2, p53, ki-67, CD44, laminin and collagen IV in evaluating prognostic significance.
Zavrides H; Zizi-Sermpetzoglou A; Elemenoglou I; Papatheofanis I; Peros G; Athanasas G; Panousopoulos D
Pol J Pathol; 2006; 57(3):149-59. PubMed ID: 17219742
[TBL] [Abstract][Full Text] [Related]
20. p22/WAF1 expression in human colorectal carcinoma: association with p53, transcription factor AP-2 and prognosis.
Ropponen KM; Kellokoski JK; Lipponen PK; Pietiläinen T; Eskelinen MJ; Alhava EM; Kosma VM
Br J Cancer; 1999 Sep; 81(1):133-40. PubMed ID: 10487624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
